Stocks to watch today, March 06: Discover key updates on Vodafone Idea, Wipro, Dr Reddy’s, and more—track the latest stock…
The acquisition has been valued at $32.15 million (approximately Rs 295 crore), the company disclosed under Regulation 30 of Sebi’s…
From pharma to media, eight Indian stocks earn ‘Buy’ calls from multiple brokerages, with upside potential touching 90%.
Track key stock moves as Indian firms release earnings and leadership updates—review complete financial highlights now!
Discover 5 major healthcare changes expected in Budget 2026, including cheaper meds and new tax rules—see what industry experts recommend.
The year 2025 has been a significant one for the Indian pharmaceutical sector. It witnessed several novel launches, collaborations, digital…
Track key stock moves for SAIL, JSW Energy, Paytm, and more amid major corporate developments—explore today’s top market highlights.
Track TCS, Sun Pharma, and sector leaders as Nifty eyes higher targets; spot key stocks for your Monday investment moves…
Explore 3 top defensive stocks for your 2026 portfolio to balance risk and stability—find out which companies to watch now!
Stocks to watch today, November 25: GIFT Nifty indicates a positive start for domestic indices. Here are the top stocks…
Discover JM Financial’s 3 top stock picks with up to 50% upside—read their latest analysis and take advantage of these…
Indian pharma exporters had for several months faced the rhetoric and threats from the Trump administration to impose tariffs on…
Discover 10 top brokerage stock picks with up to 22% upside this week—see which shares could boost your portfolio now!
Dr Reddy’s Q2 FY26 profit rises 6% YoY to ₹1,426 crore; revenue up 9% to Rs 8,805 crore, but margins…
Track top stocks like Infosys, Tata Motors, LTIMindtree, PNB, and more as Dalal Street opens for an eventful trading day—see…
Track key stocks like Vedanta, Adani Power, RailTel, and Aditya Birla Capital as major announcements drive market action today—see the…
Investors are increasingly turning to ‘safer’ MNC pharma stocks with a domestic focus at a time when the Trump administration…
Nomura’s June 2025 analysis shows Indian pharma majors like Sun Pharma, Dr. Reddy’s, Cipla, Lupin, and Zydus posting strong specialty…